Boston Scientific buy UBS Group AG
Start price
17.12.25
/
50%
€80.20
Target price
17.12.26
-
Performance (%)
-34.21%
Price
12:01
€52.76
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Boston Scientific is performing very badly with a performance of -34.21%. This prediction currently runs until 17.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Boston Scientific | -3.553% | -3.553% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by UBS_Group_AG for this prediction
In the thread Boston Scientific diskutieren
Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for BSX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Boston Scientific
Boston Scientific
Start price
Target price
Perf. (%)
€102.00
07.02.25
07.02.25
€125.53
07.02.26
07.02.26
-38.24%
08.02.26
08.02.26
Boston Scientific
Start price
Target price
Perf. (%)
€68.50
25.04.24
25.04.24
€83.95
25.04.25
25.04.25
30.51%
26.04.25
26.04.25